Literature DB >> 12748345

A retrospective 5-year study in Moldova of acute renal failure due to leptospirosis: 58 cases and a review of the literature.

Adrian Covic1, David J A Goldsmith, Paul Gusbeth-Tatomir, Anca Seica, Maria Covic.   

Abstract

BACKGROUND: Renal involvement [as acute renal failure (ARF)] is a prominent feature of both mild and severe leptospirosis-a re-emerging infectious disease. Few large series describe in detail clinical and laboratory features of cases with ARF and their outcome.
METHODS: We performed a retrospective analysis (1997-2001) of all consecutive, serological confirmed leptospirosis cases with ARF (n=58, 53 male, age 44+/-13 years, rural residents=31%, animal contact=88%.
RESULTS: Clinical manifestations (>50% prevalence): oliguria 95%, fever and jaundice 93%, nausea and vomiting 83%, haemorrhagic diathesis 80%, headache, hepatomegaly 76%, myalgias, abdominal pain 70%, hypotension 62%, disturbed consciousness 50%. A pattern of multiple organ failure (MOF) was frequent: ARF together with hepatic failure in 72%, respiratory failure in 38%, circulatory failure in 33%, pancreatitis in 25% and rhabdomyolysis in 5% of cases. Renal dysfunction: 35% of cases had a renal K(+)-wasting defect and 43% a FE(Na)(+)>1% and low-osmolarity urine despite volume depletion. Haematuria was encountered in 12 and mild proteinuria in 10 subjects. OUTCOME: 26% deaths, 64% normal hepatic and renal function at 90 days from presentation (however 29% maintained the initial tubular defect), 10% persistent mild renal failure. All deceased patients had, beside ARF, at least two other organ failures, affected consciousness, and haemorrhagic diathesis vs a prevalence for the above features of only 34, 33, and 72%, respectively, in the survivors group (P<0.05).
CONCLUSIONS: Leptospirosis presenting with ARF is a severe disease, frequently leading to MOF and to death in one-third of the patients. In particular, the haemorrhagic diathesis and cerebral involvement are markers for unfavourable patient and renal outcomes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12748345     DOI: 10.1093/ndt/gfg095

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  24 in total

1.  Case report: severe, symptomatic hypomagnesemia in acute leptospirosis.

Authors:  Anne Spichler; Daniel A Athanazio; Juvencio Furtado; Antonio Seguro; Joseph M Vinetz
Journal:  Am J Trop Med Hyg       Date:  2008-12       Impact factor: 2.345

Review 2.  The kidney in leptospirosis.

Authors:  Regina C R M Abdulkader; Marcos Vinicius Silva
Journal:  Pediatr Nephrol       Date:  2008-04-30       Impact factor: 3.714

3.  Outpatient follow-up of patients hospitalized for acute leptospirosis.

Authors:  Anne Spichler; Daniel Athanazio; Antonio C Seguro; Joseph M Vinetz
Journal:  Int J Infect Dis       Date:  2011-05-25       Impact factor: 3.623

4.  Leptospira santorosai Serovar Shermani detergent extract induces an increase in fibronectin production through a Toll-like receptor 2-mediated pathway.

Authors:  Ya-Chung Tian; Cheng-Chieh Hung; Yi-Jung Li; Yung-Chang Chen; Ming-Yang Chang; Tzung-Hai Yen; Hsiang-Hao Hsu; Mai-Szu Wu; Aled Phillips; Chih-Wei Yang
Journal:  Infect Immun       Date:  2010-12-20       Impact factor: 3.441

Review 5.  Leptospirosis in humans.

Authors:  David A Haake; Paul N Levett
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

6.  Leptospirosis in the tropics and in travelers.

Authors:  Jessica N Ricaldi; Joseph M Vinetz
Journal:  Curr Infect Dis Rep       Date:  2006-01       Impact factor: 3.725

7.  Leptospira seropositivity as a risk factor for Mesoamerican Nephropathy.

Authors:  Alejandro Riefkohl; Oriana Ramírez-Rubio; Rebecca L Laws; Michael D McClean; Daniel E Weiner; James S Kaufman; Renee L Galloway; Sean V Shadomy; Marta Guerra; Juan José Amador; José Marcel Sánchez; Damaris López-Pilarte; Chirag R Parikh; Jessica H Leibler; Daniel R Brooks
Journal:  Int J Occup Environ Health       Date:  2017-02-17

8.  Developing a clinically relevant classification to predict mortality in severe leptospirosis.

Authors:  Senaka Rajapakse; Chaturaka Rodrigo; Rashan Haniffa
Journal:  J Emerg Trauma Shock       Date:  2010-07

9.  Severe leptospirosis observed in a man who had just returned from abroad.

Authors:  Galya Gancheva; Milena Karcheva
Journal:  Balkan Med J       Date:  2013-03-01       Impact factor: 2.021

10.  Severe leptospirosis in non-tropical areas: a nationwide, multicentre, retrospective study in French ICUs.

Authors:  Arnaud-Félix Miailhe; Emmanuelle Mercier; Adel Maamar; Jean-Claude Lacherade; Aurélie Le Thuaut; Aurélie Gaultier; Pierre Asfar; Laurent Argaud; Antoine Ausseur; Adel Ben Salah; Vlad Botoc; Karim Chaoui; Julien Charpentier; Christophe Cracco; Nicolas De Prost; Marie-Line Eustache; Alexis Ferré; Elena Gauvin; Suzanne Goursaud; Maximilien Grall; Philippe Guiot; Maud Jonas; Fabien Lambiotte; Mickael Landais; Jérémie Lemarié; Olivier Lesieur; Claire Lhommet; Philippe Michel; Yannick Monseau; Sébastien Moschietto; Saad Nseir; David Osman; Jérome Pillot; Gaël Piton; Nicholas Sedillot; Michel Sirodot; Didier Thevenin; Lara Zafrani; Yoann Zerbib; Pascale Bourhy; Jean-Baptiste Lascarrou; Jean Reignier
Journal:  Intensive Care Med       Date:  2019-10-25       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.